Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP
Healthcare utilisation increases with Long COVID symptoms More than 15,000 people are taking part in the LongCOVID study conducted by RIVM. Participants with existing long-term symptoms after COVID-19 (Long COVID) reported higher healthcare utilisation.
Sewage research: decline of novel coronavirus in the Netherlands The first results of RIVM’s National Wastewater Surveillance show that the novel coronavirus in sewage is decreasing in the Netherlands.
Many people willing to isolate at home in case of positive COVID-19 test The sense of threatening danger from the novel coronavirus is declining. People are feeling less anxious and despondent than in the initial phase of the coronavirus pandemic.
Corona crisis has limited impact on infant participation in National Immunisation Programme Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
Initial results on how COVID-19 spreads within Dutch families The novel coronavirus is primarily spread amongst adults who are about the same age. Within families, the virus is mainly transmitted from adults to children.
RIVM launches study on coronavirus herd immunity RIVM has launched a large-scale study to investigate how many people have antibodies for the novel coronavirus (COVID-19).
Novel coronavirus found in wastewater The novel coronavirus that causes COVID-19 has been detected in wastewater in the Netherlands, according to RIVM research.
Additional measures novel coronavirus COVID-19 RIVM has advised the Dutch government that additional measures are needed throughout the Netherlands to prevent the spread of COVID-19.
Results of random sample test: 4% of hospital staff infected with coronavirus Nearly four per cent of the hospital staff examined in Brabant is infected with the novel coronavirus (COVID-19). A random sample test by RIVM between 6 and 9 March reveals this.